Elizabeth Bray Norton

Title: Innovations by Elizabeth Bray Norton

Introduction

Elizabeth Bray Norton is an accomplished inventor based in New Orleans, Louisiana. She has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic agents. With a total of two patents to her name, her work focuses on addressing critical health issues through novel approaches.

Latest Patents

One of her latest patents is titled "Mutated E. coli enterotoxins as anti-inflammatory agents." This invention provides compositions and methods for reducing symptoms of inflammation by administering therapeutically effective amounts of enterotoxins that interfere with the function of ADP-ribosylation factor. The invention also includes a carrier that facilitates the internalization of these subunits into cells. Another notable patent is "Primary mesenchymal stem cells as a vaccine platform." This patent describes episomally transfected primary mesenchymal stem cells that express polypeptides related to pathogens. The methods outlined in this patent aim to treat or prevent infections using these engineered cells.

Career Highlights

Elizabeth Bray Norton is associated with the Administrators of the Tulane Educational Fund, where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on therapeutic strategies in medicine.

Collaborations

Some of her notable coworkers include John D. Clements and Suzanne L. Tomchuck, who contribute to her research endeavors and collaborative projects.

Conclusion

Elizabeth Bray Norton exemplifies the spirit of innovation in biotechnology through her patents and research. Her contributions are paving the way for new therapeutic solutions to combat inflammation and infectious diseases.